CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
A randomized controlled multicenter trial of high dose ursodesoxycholic acid versus placebo in sepsis-assoicated cholestasis
DOI 10.1055/s-0030-1254616
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Kramer, R Stauber, K Lenz, N Schusterschitz, M Trauner, M Joannidis
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Sepsis-associated cholestasis (SAC) is increasingly recognised in criticall ill patients. SAC may ultimately progress to secondary sclerosing cholangitis, eventually causing biliary sepsis and progressive hepatic failure. Apart from interventional ERCP aiming to clear obstructed ducts in patients with secondary sclerosing cholangitis, no effective medical treatment is established in progressive SAC. We h…
Zitieren
Zitierempfehlung
L Kramer, R Stauber, K Lenz, N Schusterschitz, M Trauner, M Joannidis (2010) A randomized controlled multicenter trial of high dose ursodesoxycholic acid versus placebo in sepsis-assoicated cholestasis. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0030-1254616
Mit CareLit weiterarbeiten